At the time of writing, Olema Pharmaceuticals Inc [OLMA] stock is trading at $8.0, up 2.96%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The OLMA shares have gain 5.54% over the last week, with a monthly amount glided 52.09%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Olema Pharmaceuticals Inc [NASDAQ: OLMA] stock has seen the most recent analyst activity on August 12, 2025, when Citigroup reiterated its Buy rating and also boosted its price target to $21 from $20. Previously, Goldman started tracking the stock with Buy rating on April 02, 2024, and set its price target to $24. On January 30, 2024, Citigroup initiated with a Buy rating and assigned a price target of $20 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $21 on July 21, 2023. CapitalOne initiated its recommendation with a Overweight and recommended $16 as its price target on May 05, 2023. Credit Suisse started tracking with a Outperform rating for this stock on February 22, 2023, and assigned it a price target of $12.
For the past year, the stock price of Olema Pharmaceuticals Inc fluctuated between $2.86 and $13.93. Currently, Wall Street analysts expect the stock to reach $28.5 within the next 12 months. Olema Pharmaceuticals Inc [NASDAQ: OLMA] shares were valued at $8.0 at the most recent close of the market. An investor can expect a potential return of 256.25% based on the average OLMA price forecast.
Analyzing the OLMA fundamentals
Gross Profit Margin for this corporation currently stands at -0.11% with Operating Profit Margin at -431.66%, Pretax Profit Margin comes in at -390.92%, and Net Profit Margin reading is -390.92%. To continue investigating profitability, this company’s Return on Assets is posted at -0.37, Equity is -0.43 and Total Capital is -0.45. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Olema Pharmaceuticals Inc [NASDAQ:OLMA] has a current ratio of 15.22. In addition, the Quick Ratio stands at 15.22 and the Cash Ratio stands at 1.58.
Transactions by insiders
Recent insider trading involved Bain Capital Life Sciences Inv, 10% Owner, that happened on Jan 08 ’25 when 0.3 million shares were purchased. Director, Graham G. Walmsley completed a deal on Dec 17 ’24 to sell 0.7 million shares. Meanwhile, Affiliate Logos Opportunities Fund I LP bought 0.7 million shares on Dec 13 ’24.
